During the past decade, Polyclinique Côte Basque Sud conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Polyclinique Côte Basque Sud" are "Adenocarcinoma of Rectum" (1 trials), "Colonic Adenocarcinoma" (1 trials), "Colorectal Cancer" (1 trials), "Colorectal Neoplasms" (1 trials) and "Patient Centred Care" (1 trials). Many other conditions were trialed in "Polyclinique Côte Basque Sud" in a lesser frequency.

Most popular intervention types in "Polyclinique Côte Basque Sud" are "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFORINOX" (1 trials), "FOLFOX4 or XELOX" (1 trials), "Intensive Monitoring CEA" (1 trials), "Intensive Monitoring Imagery" (1 trials) and "LV5FU2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Côte Basque Sud" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Polyclinique Côte Basque Sud". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Polyclinique Côte Basque Sud, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Côte Basque Sud, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".